DACTINOMYCIN
Generic: DACTINOMYCIN
Hisun Pharmaceuticals USAManufacturer
INTRAVENOUSRoute
DACTINOMYCINActive Substance
2019-07-16Original Approval
DACTINOMYCIN is FDA application ANDA207232, sponsored by HISUN PHARM HANGZHOU. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
281 reports
2
FEBRILE NEUTROPENIA
192 reports
3
PRODUCT USE IN UNAPPROVED INDICATION
132 reports
4
NEUTROPENIA
126 reports
5
DRUG INEFFECTIVE
115 reports
6
VOMITING
104 reports
7
THROMBOCYTOPENIA
103 reports
8
PYREXIA
90 reports
9
ANAEMIA
86 reports
10
DISEASE PROGRESSION
85 reports